| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology and Neurological Surgery (Neurology) (Drs. Racette, Mink, Videen, Perlmutter, and L. McGee–Minnich), Pediatrics (Dr. Mink), Anatomy & Neurobiology (Drs. Mink and Perlmutter), American Parkinson Disease Association Advanced Center for Parkinson Research (Drs. Racette, Mink, Perlmutter, and L. McGee–Minnich), and the Mallinckrodt Institute of Radiology (Drs. Moerlein, Videen, and Perlmutter), Washington University School of Medicine, St. Louis, MO.
Address correspondence and reprint requests to Dr. Brad A. Racette, Washington University School of Medicine, 660 South Euclid Avenue, Box 8111, St. Louis, MO 63110; e-mail: racetteb{at}neuro.wustl.edu
Objective: To determine whether welding-related parkinsonism differs from idiopathic PD. Background: Welding is considered a cause of parkinsonism, but little information is available about the clinical features exhibited by patients or whether this is a distinct disorder. Methods: The authors performed a case-control study that compared the clinical features of 15 career welders, who were ascertained through an academic movement disorders center and compared to two control groups with idiopathic PD. One control group was ascertained sequentially to compare the frequency of clinical features, and the second control group was sex- and age-matched to compare the frequency of motor fluctuations. Results: Welders were exposed to a mean of 47,144 welding hours. Welders had a younger age at onset (46 years) of PD compared with sequentially ascertained controls (63 years; p < 0.0001). There was no difference in frequency of tremor, bradykinesia, rigidity, asymmetric onset, postural instability, family history, clinical depression, dementia, or drug-induced psychosis between the welders and the two control groups. All treated welders responded to levodopa. Motor fluctuations and dyskinesias occurred at a similar frequency in welders and the two control groups. PET with 6-[18F]fluorodopa obtained in two of the welders showed findings typical of idiopathic PD, with greatest loss in posterior putamen. Conclusions: Parkinsonism in welders is distinguished clinically only by age at onset, suggesting welding may be a risk factor for PD. These preliminary data cannot exclude a genetic contribution to susceptibility in these exposed individuals.
This article has been cited by other articles:
|
|
 |
|
  V. A. Fitsanakis, N. Zhang, J. G. Anderson, K. M. Erikson, M. J. Avison, J. C. Gore, and M. Aschner Measuring Brain Manganese and Iron Accumulation in Rats following 14 Weeks of Low-Dose Manganese Treatment Using Atomic Absorption Spectroscopy and Magnetic Resonance Imaging Toxicol. Sci., May 1, 2008; 103(1): 116 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Stepens, I. Logina, V. Liguts, P. Aldins, I. Eksteina, A. Platkajis, I. Martinsone, E. Terauds, B. Rozentale, and M. Donaghy A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese N. Engl. J. Med., March 6, 2008; 358(10): 1009 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Milatovic, Z. Yin, R. C. Gupta, M. Sidoryk, J. Albrecht, J. L. Aschner, and M. Aschner Manganese Induces Oxidative Impairment in Cultured Rat Astrocytes Toxicol. Sci., July 1, 2007; 98(1): 198 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Y Baek, Y H Kim, S O Oh, C-R Lee, C I Yoo, J H Lee, H Lee, C S Sim, J Park, J-W Kim, et al. Manganese does not alter the severe neurotoxicity of MPTP Human and Experimental Toxicology, March 1, 2007; 26(3): 203 - 211. [Abstract] [PDF]
|
|
|
|
 |
|
 R. M Bowler, H. A Roels, S. Nakagawa, M. Drezgic, E. Diamond, R. Park, W. Koller, R. P Bowler, D. Mergler, M. Bouchard, et al. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders Occup. Environ. Med., March 1, 2007; 64(3): 167 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dick, S. Semple, F. Dick, and A. Seaton Occupational titles as risk factors for Parkinson's disease Occup. Med., January 1, 2007; 57(1): 50 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Racette, A. Bradley, C. A. Wrisberg, and J. S. Perlmutter The impact of litigation on neurologic research Neurology, December 26, 2006; 67(12): 2124 - 2128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Guilarte, J. L. McGlothan, M. Degaonkar, M.-K. Chen, P. B. Barker, T. Syversen, and J. S. Schneider Evidence for Cortical Dysfunction and Widespread Manganese Accumulation in the Nonhuman Primate Brain following Chronic Manganese Exposure: A 1H-MRS and MRI Study Toxicol. Sci., December 1, 2006; 94(2): 351 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C M Fored, J P Fryzek, L Brandt, G Nise, B Sjogren, J K McLaughlin, W J Blot, and A Ekbom Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders Occup. Environ. Med., February 1, 2006; 63(2): 135 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Frigerio, A. Elbaz, K. R. Sanft, B. J. Peterson, J. H. Bower, J. E. Ahlskog, B. R. Grossardt, M. de Andrade, D. M. Maraganore, and W. A. Rocca Education and occupations preceding Parkinson disease: A population-based case-control study Neurology, November 22, 2005; 65(10): 1575 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Goldman, C. M. Tanner, C. W. Olanow, R. L. Watts, R. D. Field, and J. W. Langston Occupation and parkinsonism in three movement disorders clinics Neurology, November 8, 2005; 65(9): 1430 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kieburtz and R. Kurlan Welding and Parkinson disease: Is there a bond? Neurology, June 28, 2005; 64(12): 2001 - 2003. [Full Text] [PDF]
|
|
|
|
|
|
J. Jankovic Searching for a relationship between manganese and welding and Parkinson's disease Neurology, June 28, 2005; 64(12): 2021 - 2028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Josephs, J. E. Ahlskog, K. J. Klos, N. Kumar, R. D. Fealey, M. R. Trenerry, and C. T. Cowl Neurologic manifestations in welders with pallidal MRI T1 hyperintensity Neurology, June 28, 2005; 64(12): 2033 - 2039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Racette, S. D. Tabbal, D. Jennings, L. Good, J. S. Perlmutter, and B. Evanoff Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders Neurology, January 25, 2005; 64(2): 230 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B A Racette, G J Esper, J Antenor, K J Black, A Burkey, S M Moerlein, T O Videen, V Kotagal, J G Ojemann, and J S Perlmutter Pathophysiology of parkinsonism due to hydrocephalus J. Neurol. Neurosurg. Psychiatry, November 1, 2004; 75(11): 1617 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.-S. Chu, W. C. Koller, and K. E. Lyons Effect of levodopa treatment for parkinsonism in welders: A double-blind study Neurology, October 26, 2004; 63(8): 1541 - 1541. [Full Text] [PDF]
|
|
|
|
|
|
W. C. Koller, K. E. Lyons, and W. Truly Effect of levodopa treatment for parkinsonism in welders: A double-blind study Neurology, March 9, 2004; 62(5): 730 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.M. Powers, T. Smith-Weller, G.M. Franklin, W.T. Longstreth Jr., P.D. Swanson, and H. Checkoway Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes Neurology, June 10, 2003; 60(11): 1761 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Sadak, P. E. Schulz, B. A. Racette, and J. S. Perlmutter Welding-related parkinsonism: Clinical features, treatment, and pathophysiology Neurology, November 13, 2001; 57(9): 1738 - 1739. [Full Text] [PDF]
|
|
|
|
|
|
G. Pezzoli, M. Canesi, B. Ravina, A. Siderowf, J. Farrar, H. Hurtig, A. H. Rajput, and B. A. Racette Welding-related parkinsonism: Clinical features, treatment, and pathophysiology Neurology, September 11, 2001; 57(5): 936 - 937. [Full Text] [PDF]
|
|
|
|
 |
|
 Welding May Be an Environmental Trigger for Parkinson's Disease Journal Watch Neurology, April 12, 2001; 2001(412): 5 - 5. [Full Text]
|
|
|
|
|
|
A. H. Rajput Environmental toxins accelerate Parkinson's disease onset Neurology, January 9, 2001; 56(1): 4 - 5. [Full Text] [PDF]
|
|
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
